Search

everythinglearnresearchcommunity

for

Search:↓

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

AIDS may cause changes in the scalp that increase infection risk and hair loss.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Most HIV patients in the study showed skin and mucous membrane issues, with oral thrush being the most common.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

CD4+ skin cells may be precursors to basal cell carcinoma.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.